About Assertio (ASRT)
Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Susp... Read more
- USD0.70
- USD0.74
- USD0.69
- USD1.80
- -11.10%
- 125M
- 1.00
- 382.32k
- 69M
- 0.68
- -31.20%
Stock News
9 hours ago
BlackRock EuroFund Q4 2024 Commentary
SeekingAlpha
9 hours ago
GGUS Vs. IWF: Why Large Tech Allocation Matters Even Now, Go With IWF
SeekingAlpha
yesterday
As investors hunt for reasons to sell stocks, I'm stepping in to buy — here's why
CNBC
yesterday
Roku: Still A Long Runway For Growth, But Watch For Valuation
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
